ORIC (oricpharma.com) Enterprise Value-to-Revenue Coefficient

Official company branding of ORIC Pharmaceuticals Inc (ORIC)

Adherence to ESG standards for waste reduction and energy efficiency in ORIC Pharmaceuticals laboratories creates a sustainable foundation for growth. ORIC Pharmaceuticals focuses on suppressing tumor survival mechanisms through collaboration with oncology centers. The company's patent portfolio and partnerships with industry behemoths strengthen its market position. The company's EV/Sales valuation demonstrates price dynamics, where 0.00 becomes the new value of the metric.

oricpharma.com (ORIC): EV/Sales Multiple from 11/23/2025 to 11/19/2026

Financial and market metric breakdowns for ORIC Pharmaceuticals, Inc. (ORIC)

- business market valuation indicators:
Fundamental company valuation:ORIC Pharmaceuticals ORIC
Product sample of oricpharma.com

This indicator determines the market value of a business relative to its revenue, excluding the impact of debt load. By analyzing the company's value-to-revenue trend, an investor assesses the objective attractiveness of the asset without considering leverage. The metric compares the total enterprise value with sales volume to identify overbought or undervalued conditions. For ORIC Pharmaceuticals (ORIC), this calculation is supported by the high efficiency of its research and development capabilities. Stable laboratory utilization provides the fundamental basis for current market quotes.